secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2023-04-17T23:59:59+00:00
Accession:  0001493152-23-012602
Event type: litigation
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera settles litigation with Biofrontera AG, expands board, amends rights plan
--------------------------------------------------------------------------------

- Settlement resolves Delaware Chancery lawsuit and challenges to Biofrontera AG's January 2023 shareholder meeting.
- Board expands from 5 to 6; Biofrontera AG appoints one Class I director; will add seventh director for 2023 annual meeting.
- Rights Agreement amended: Biofrontera AG's beneficial ownership threshold raised from 20% to 29.96%.
- Related Party Transactions Committee established to approve all deals between Biofrontera Inc. and Biofrontera AG.
- Standstill: Biofrontera AG cannot buy additional shares without committee OK; must vote with Board through 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223012602/0001493152-23-012602-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223012602/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-012602

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer